You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 12, December 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prediction of Tricyclic Antidepressant Response

A Critical Review

Robert J. Bielski, MD; Robert O. Friedel, MD

Arch Gen Psychiatry. 1976;33(12):1479-1489.


Abstract

• This article reviews all the prospective, double-blind controlled studies that have evaluated the prediction of response to imipramine hydrochloride and amitriptyline hydrochloride in depressed patients. Despite widely divergent methodologies, an attempt is made to extract clinically useful conclusions from these data. Critiques of each study and the criteria used in their evaluation are presented, with suggestions for future research included. The predictors of positive response to imipramine and amitriptyline are as follows: upper socioeconomic class, insidious onset, anorexia, weight loss, middle and late insomnia, and psychomotor disturbance. The predictors of poor response are the following: neurotic, hypochondriacal, and hysterical traits, multiple prior episodes, and delusions. Pretreatment urinary 3methoxy-4-hydroxyphenylglycol (MHPG) levels may some day be useful in predicting to which of these two tricyclic antidepressants a patient will respond.



Author Affiliations

From the Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle. Dr Bielski is now with the Department of Psychiatry, Michigan State University, East Lansing, Mich.


Footnotes

Accepted for publication Sept 1, 1976.

Reprint requests to Department of Psychiatry and Behavioral Sciences RP-10, University of Washington School of Medicine, Seattle, WA 98195 (Dr Friedel),



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
Trivedi et al.
Am. J. Psychiatry 2006;163:28-40.
ABSTRACT | FULL TEXT  

Predictors of Early Recovery From Major Depression Among Persons Admitted to Community-Based Clinics: An Observational Study
Meyers et al.
Arch Gen Psychiatry 2002;59:729-735.
ABSTRACT | FULL TEXT  

Personality Pathology and Treatment Outcome in Major Depression: A Review
Mulder
Am. J. Psychiatry 2002;159:359-371.
ABSTRACT | FULL TEXT  

A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Posternak et al.
Am. J. Psychiatry 2002;159:191-200.
ABSTRACT | FULL TEXT  

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
Anderson et al.
J Psychopharmacol 2000;14:3-20.
ABSTRACT  

Clinical trials in psychiatry: background and statistical perspective
Johnson
Stat Methods Med Res 1998;7:209-234.
ABSTRACT  

Chronological Milestones to Guide Drug Change: When Should Clinicians Switch Antidepressants?
Quitkin et al.
Arch Gen Psychiatry 1996;53:785-792.
ABSTRACT  

Drug Treatment of Depression
Brown and Bryant
Journal of Pharmacy Practice 1990;3:252-261.
ABSTRACT  

Relevance of DMS-III Depressive Subtype and Chronicity of Antidepressant Efficacy in Atypical Depression: Differential Response to Phenelzine, Imipramine, and Placebo
Stewart et al.
Arch Gen Psychiatry 1989;46:1080-1087.
ABSTRACT  

National Institute of Mental Health Treatment of Depression Collaborative Research Program: General Effectiveness of Treatments
Elkin et al.
Arch Gen Psychiatry 1989;46:971-982.
ABSTRACT  

Phenelzine and Imipramine in Mood Reactive Depressives: Further Delineation of the Syndrome of Atypical Depression
Quitkin et al.
Arch Gen Psychiatry 1989;46:787-793.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Doxepin Treatment of Depressed Patients With Chronic Obstructive Pulmonary Disease
Light et al.
Arch Intern Med 1986;146:1377-1380.
ABSTRACT  

Low Levels and Lack of Predictors of Somatotherapy and Psychotherapy Received by Depressed Patients
Keller et al.
Arch Gen Psychiatry 1986;43:458-466.
ABSTRACT  

Treatment Outcome Validation of DSM-III Depressive Subtypes: Clinical Usefulness in Outpatients With Mild to Moderate Depression
Stewart et al.
Arch Gen Psychiatry 1985;42:1148-1153.
ABSTRACT  

NIMH Treatment of Depression Collaborative Research Program: Background and Research Plan
Elkin et al.
Arch Gen Psychiatry 1985;42:305-316.
ABSTRACT  

Subtypes of Depression: Family Study Perspective
Leckman et al.
Arch Gen Psychiatry 1984;41:833-838.
ABSTRACT  

Appetite Disturbance and Excessive Guilt in Major Depression: Use of Family Study Data to Define Depressive Subtypes
Leckman et al.
Arch Gen Psychiatry 1984;41:839-844.
ABSTRACT  

The Chestnut Lodge Follow-up Study: II. Long-term Outcome of Schizophrenia and the Affective Disorders
McGlashan
Arch Gen Psychiatry 1984;41:586-601.
ABSTRACT  

The Borderline Syndrome: II. Is It a Variant of Schizophrenia or Affective Disorder?
McGlashan
Arch Gen Psychiatry 1983;40:1319-1323.
ABSTRACT  

Efficacy of Desipramine in Depressed Outpatients: Response According to Research Diagnostic Criteria Diagnoses and Severity of Illness
Stewart et al.
Arch Gen Psychiatry 1983;40:202-207.
ABSTRACT  

Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression
Paykel et al.
Arch Gen Psychiatry 1982;39:1041-1049.
ABSTRACT  

Clomipramine and Doxepin in Depressive Neurosis: Plasma Levels and Therapeutic Response
Linnoila et al.
Arch Gen Psychiatry 1980;37:1295-1299.
ABSTRACT  

Phenelzine and Amitriptyline in the Treatment of Depression: A Comparison of Present and Past Studies
Ravaris et al.
Arch Gen Psychiatry 1980;37:1075-1080.
ABSTRACT  

Novel Antidepressants and the Biogenic Amine Hypothesis of Depression: The Case for Iprindole and Mianserin
Zis and Goodwin
Arch Gen Psychiatry 1979;36:1097-1107.
ABSTRACT  

Urinary MHPG Levels and Tricyclic Antidepressant Drug Selection: A Preliminary Communication on Improved Drug Selection in Clinical Practice
Cobbin et al.
Arch Gen Psychiatry 1979;36:1111-1115.
ABSTRACT  

Biologic Correlates of Psychoanalytic Concepts
Heilbrunn
J Am Psychoanal Assoc 1979;27:597-626.
 

Primary Affective Disorder, Clinical State Change, and MHPG Excretion: A Longitudinal Study
Pickar et al.
Arch Gen Psychiatry 1978;35:1378-1383.
ABSTRACT  

The Use of Antidepressants in Clinical Practice
Klerman and Hirschfeld
JAMA 1978;240:1403-1406.
ABSTRACT  

Drug Spotlight Program: Treatment of Depression with Drugs
HOLLISTER
ANN INTERN MED 1978;89:78-84.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.